These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25737985)

  • 21. [Characterization and determination of antibiotic resistance profiles of a single clone Acinetobacter baumannii strains isolated from blood cultures].
    Karagöz A; Baran I; Aksu N; Acar S; Durmaz R
    Mikrobiyol Bul; 2014 Oct; 48(4):566-76. PubMed ID: 25492652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of Biofilm Formation and Resistance to Imipenem and Ciprofloxacin among Clinical Isolates of Acinetobacter baumannii in Tehran.
    Abdi-Ali A; Hendiani S; Mohammadi P; Gharavi S
    Jundishapur J Microbiol; 2014 Jan; 7(1):e8606. PubMed ID: 25147652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of multidrug-resistant
    Sun L; Wang X; Li Z
    Br J Neurosurg; 2018 Dec; 32(6):642-645. PubMed ID: 28431478
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of antimicrobial resistance of Acinetobacter baumannii clinical isolates from Shanghai and Hong Kong.
    Ling TK; Ying CM; Lee CC; Liu ZK
    Med Princ Pract; 2005; 14(5):338-41. PubMed ID: 16103700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Turk Dagi H; Kus H; Arslan U; Tuncer I
    Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Elbehiry A; Marzouk E; Moussa IM; Dawoud TM; Mubarak AS; Al-Sarar D; Alsubki RA; Alhaji JH; Hamada M; Abalkhail A; A Hemeg H; Zahran RN
    Saudi J Biol Sci; 2021 Jan; 28(1):1158-1166. PubMed ID: 33424412
    [No Abstract]   [Full Text] [Related]  

  • 27. Molecular identification of Acinetobacter baumannii isolated from intensive care units and their antimicrobial resistance patterns.
    Ghajavand H; Esfahani BN; Havaei SA; Moghim S; Fazeli H
    Adv Biomed Res; 2015; 4():110. PubMed ID: 26261812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial susceptibility of clinical isolates of Acinetobacter baumannii.
    Shi ZY; Liu PY; Lau Y; Lin Y; Hu BS; Shir J-M
    Diagn Microbiol Infect Dis; 1996 Feb; 24(2):81-5. PubMed ID: 9147913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between ability of biofilm formation with their responsible genes and MDR patterns in clinical and environmental Acinetobacter baumannii isolates.
    Bardbari AM; Arabestani MR; Karami M; Keramat F; Alikhani MY; Bagheri KP
    Microb Pathog; 2017 Jul; 108():122-128. PubMed ID: 28457900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pan drug-resistant
    Sobouti B; Mirshekar M; Fallah S; Tabaei A; Fallah Mehrabadi J; Darbandi A
    Med J Islam Repub Iran; 2020; 34():24. PubMed ID: 32551313
    [No Abstract]   [Full Text] [Related]  

  • 31. Frequency of
    Fallah A; Rezaee MA; Hasani A; Barhaghi MHS; Kafil HS
    Iran J Basic Med Sci; 2017 Aug; 20(8):849-855. PubMed ID: 29085575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CLSI based antibiogram profile and the detection of MDR and XDR strains of
    Girija As S; Priyadharsini J V
    Med J Islam Repub Iran; 2019; 33():3. PubMed ID: 31086782
    [No Abstract]   [Full Text] [Related]  

  • 33. [Analysis of drug resistance of Pseudomonas aeruginosa and use of antibiotics in burn wards during 6 years].
    Dou Y; Zhang Q
    Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):9-14. PubMed ID: 24684983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains].
    Cıkman A; Ceylan MR; Parlak M; Karahocagil MK; Berktaş M
    Mikrobiyol Bul; 2013 Jan; 47(1):147-51. PubMed ID: 23390912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virulence Characteristics of Biofilm-Forming
    Khalil MAF; Ahmed FA; Elkhateeb AF; Mahmoud EE; Ahmed MI; Ahmed RI; Hosni A; Alghamdi S; Kabrah A; Dablool AS; Hetta HF; Moawad SS; Hefzy EM
    Microorganisms; 2021 Nov; 9(11):. PubMed ID: 34835490
    [No Abstract]   [Full Text] [Related]  

  • 37. Frequency of Class 1 Integron and Genetic Diversity of
    Eghbalimoghadam M; Farahani A; Akbar FN; Mohajeri P
    J Nat Sci Biol Med; 2017; 8(2):193-198. PubMed ID: 28781486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of Aminoglycoside Resistance Due to armA methylase in Multi-drug Resistant Acinetobacter Baumannii Isolates in a University Hospital in Nepal.
    Shrestha S; Tada T; Shrestha B; Kirikae T; Ohara H; Rijal BP; Pokhrel BM; Sherchand JB
    J Nepal Health Res Counc; 2016 May; 14(33):72-76. PubMed ID: 27885285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evolution of antimicrobial susceptibility of Acinetobacter baumannii clinical isolates].
    López-Hernández S; Alarcón T; López-Brea M
    Rev Esp Quimioter; 2000 Dec; 13(4):394-400. PubMed ID: 11498706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii.
    Punpanich W; Munsrichoom A; Srisarang S; Treeratweeraphong V
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S95-100. PubMed ID: 22043760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.